Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
COFCO Biotechnology Co., Ltd. (000930.SZ)
Bengbu, CN
COFCO Biotechnology Co., Ltd., established in 1998 and headquartered in Bengbu, China, specializes in the comprehensive processing and manufacturing of agricultural products across China. Its extensive product portfolio includes a variety of corn-based starches, such as edible, special, waxy, and modified waxy types. The company also supplies an array of feed ingredients, including corn gluten meal, sprayed corn husk, corn germ meal, and distillers' dried grains with solubles (DDGS), as well as raw materials for fertilizers and glutamic acid residue. COFCO Biotechnology manufactures diverse sweeteners like fructose and functional sugar alcohols, alongside fuel and edible alcohols, and even liquors. Biochemicals such as monosodium glutamate, citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E are also key outputs. Beyond these, its offerings extend to various edible oils (including corn crude, corn germ, rapeseed, peanut, and soybean oil), a range of syrups (fructose, maltose, glucose, oligomeric isomalt, and beer syrups), and essential packaging solutions (plastic woven bags, barrels, container bags, and diverse paper products). Additional specialized products encompass corn fiber feed, bacterial protein, microorganisms, compound antioxidants, and nutritious health foods. COFCO Biotechnology also provides essential support services like warehousing, logistics, and information consulting. Furthermore, the company's operational scope is remarkably broad, encompassing research and development in biological engineering, the production and sale of amino acids and both compound and organic fertilizers, and the trade of chemical products and grains. Its activities extend to the wholesale and retail of edible agricultural products, the export of its own products and associated technologies, and the import of necessary raw materials, equipment, and technologies. The firm is also involved in steam production and sales, coal wholesale, food and food additive manufacturing and sales, house leasing, food procurement, power generation, and the distribution of pre-packaged, bulk, and dairy food items. The company underwent a rebranding in September 2019, transitioning from its former name, COFCO Biochemical (Anhui) Co., Ltd., to its current designation, COFCO Biotechnology Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.39% | -2.11% | -15.26% | -24.52% | -12.05% | -11.44% | -7.59% | -35.72% | -48.69% | -50.58% | +29.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.7% Q1'26: -11.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+53.3% ★ Q1'26: -400.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.7% Q1'26: -28.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+1.0% Q1'26: -2.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+0.9% Q1'26: -3.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.4% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.49× ★ Q1'26: -8.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.89B
est: 5.13B (+210.0%)
|
17.70B
est: 6.95B (+154.6%)
|
19.47B
est: 20.34B (-4.3%)
|
19.91B
est: 23.24B (-14.3%)
|
23.44B
est.
|
23.56B
est: 23.91B (-1.4%)
|
20.38B
est: 20.98B (-2.9%)
|
19.92B
est: 20.98B (-5.0%)
|
20.05B
est: 20.40B (-1.7%)
|
17.51B
est: 20.62B (-15.1%)
|
16.87B
16.87B – 16.87B
-18.2% YoY
|
17.52B
17.52B – 17.52B
+3.9% YoY
|
18.42B
18.42B – 18.42B
+5.1% YoY
|
| EBITDA |
1.92B
est: 290.38M (+561.8%)
|
1.40B
est: 393.86M (+255.1%)
|
1.26B
est: 1.15B (+9.2%)
|
1.34B
est: 1.32B (+1.7%)
|
1.33B
est.
|
1.97B
est: 1.35B (+45.8%)
|
37.08M
est: 1.19B (-96.9%)
|
1.89B
est: 1.19B (+59.1%)
|
719.23M
est: 1.04B (-31.0%)
|
684.99M
est: 1.05B (-35.0%)
|
861.94M
861.94M – 861.94M
-18.2% YoY
|
895.15M
895.15M – 895.15M
+3.9% YoY
|
941.13M
941.13M – 941.13M
+5.1% YoY
|
| EBIT |
1.31B
est: 178.24M (+634.0%)
|
789.15M
est: 241.75M (+226.4%)
|
833.24M
est: 707.26M (+17.8%)
|
902.51M
est: 807.90M (+11.7%)
|
814.71M
est.
|
1.54B
est: 831.08M (+85.1%)
|
-429.76M
est: 729.26M (-158.9%)
|
1.45B
est: 729.26M (+98.9%)
|
237.71M
est: 565.23M (-57.9%)
|
168.30M
est: 571.24M (-70.5%)
|
467.33M
467.33M – 467.33M
-18.2% YoY
|
485.34M
485.34M – 485.34M
+3.9% YoY
|
510.27M
510.27M – 510.27M
+5.1% YoY
|
| Net Income |
929.30M
est: 781.81M (+18.9%)
|
483.04M
est: 1.06B (-54.5%)
|
592.82M
est: 241.99M (+145.0%)
|
593.12M
est: 595.66M (-0.4%)
|
1.06B
est.
|
1.13B
est: 1.14B (-0.5%)
|
-601.63M
est: 949.34M (-163.4%)
|
1.06B
est: 949.34M (+11.5%)
|
25.13M
est: 74.14M (-66.1%)
|
38.37M
est: 111.21M (-65.5%)
|
-185.35M
-185.35M – -185.35M
-266.7% YoY
|
148.28M
148.28M – 148.28M
+180.0% YoY
|
444.84M
444.84M – 444.84M
+200.0% YoY
|
| SGA |
1.76B
est: 197.51M (+788.9%)
|
1.85B
est: 267.90M (+590.4%)
|
1.77B
est: 783.73M (+126.3%)
|
774.95M
est: 895.26M (-13.4%)
|
902.81M
est.
|
799.74M
est: 920.94M (-13.2%)
|
780.90M
est: 808.12M (-3.4%)
|
804.40M
est: 808.12M (-0.5%)
|
823.11M
est: 664.60M (+23.8%)
|
160.48M
est: 671.67M (-76.1%)
|
549.49M
549.49M – 549.49M
-18.2% YoY
|
570.66M
570.66M – 570.66M
+3.9% YoY
|
599.98M
599.98M – 599.98M
+5.1% YoY
|
| EPS |
0.50
est: 0.42 (+19.0%)
|
0.26
est: 0.57 (-54.4%)
|
0.32
est: 0.13 (+146.2%)
|
0.32
est: 0.32 (+0.0%)
|
0.57
est.
|
0.61
est: 0.61 (+0.0%)
|
-0.33
est: 0.51 (-164.7%)
|
0.57
est: 0.51 (+11.8%)
|
0.01
est: 0.04 (-66.3%)
|
0.02
est: 0.06 (-65.5%)
|
-0.10
-0.10 – -0.10
-266.7% YoY
|
0.08
0.08 – 0.08
+180.0% YoY
|
0.24
0.24 – 0.24
+200.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-15 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P China ETF GXC | 0.03% | 124.0K | 0.59% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 53.0K | 0.46% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 347.2K | 0.06% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 154.9K | 0.39% |
| 5 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 200.5K | 0.07% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 14.7K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 33.3K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.64M | 0.06% |
| 9 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 74.5K | 0.29% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 68.2K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Changping Hu | Chief Accountant & Financial Manager | — | male |
| De Guo Zhang | GM & Non-Independent Director | — | male |
| Jinbo Su | Board Secretary | — | — |
| Manyi Wang | General Manager | — | — |
| Rui Qiao | Deputy General Manager | — | male |
| Shao Hui Chen | Deputy General Manager | — | male |
| Xichun Pan | Board Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000930.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
